Andrew Huberman· PhD
The first place where this happened was in a class of medicines called checkpoint inhibitors. ... PD1, CTLA4 are some targets where there are drugs that are infused that hit these things that are on the surface of TE-C cells and they actually are natural breaks to the TE- cells. ... if you make a drug that hits the break on the on the tea cells, the tea cells go stronger and they can be unleashed against cancer just by taking the brakes off of them.